ClinicalTrials.gov record

Completed Not applicable Interventional Accepts healthy volunteers Results available

Rectal Microbicide Acceptability, Tolerability and Adherence

ClinicalTrials.gov ID: NCT03671239

Public ClinicalTrials.gov record NCT03671239. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Sep 3, 2026, 5:54 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Acceptability, Tolerability, and Adherence of Three Rectal Microbicide Placebo Formulations Among HIV Seronegative Cisgender Men, Transgender Men and Transgender Women Who Engage in Receptive Anal Intercourse

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

MTN-035 is a multi-site, randomized-sequence, three-period, open label crossover study that will enroll approximately 210 participants randomized (1:1:1:1:1:1) to one of six sequences of rectal microbicide placebo product application.

Study identification

NCT ID: NCT03671239
Recruitment status: Completed
Study type: Interventional
Phase: Not applicable
Lead sponsor: Microbicide Trials Network; Network
Enrollment: 217 participants

Conditions and interventions

Conditions

HIV Prevention

Interventions

Behavioral

Eligibility (public fields only)

Age range: 18 Years to 35 Years
Sex: All
Healthy volunteers: Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Apr 25, 2019
Primary completion: Jul 26, 2020
Completion: Jul 26, 2020
Last update posted: Jan 19, 2023

2019 – 2020

United States locations

U.S. sites: 3
U.S. states: 3
U.S. cities: 3

Facility	City	State	ZIP	Site status
Alabama Clinical Research Site	Birmingham	Alabama	35294	—
Bridge HIV Clinical Research Site	San Francisco	California	94102	—
University of Pittsburgh Clinical Research Site	Pittsburgh	Pennsylvania	15216	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT03671239, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Jan 19, 2023 · Synced Sep 3, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03671239 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →